{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:01:31Z","timestamp":1792026091811,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ygyno.2020.11.021","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T17:12:38Z","timestamp":1607101958000},"page":"438-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events"],"prefix":"10.1016","volume":"160","author":[{"given":"Alli M.","family":"Straubhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ms Qin C.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Cham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Long Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2017.02.023","article-title":"Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?","volume":"145","author":"Sioulas","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","volume":"119","author":"Chi","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.11.021_bb0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182","volume":"33","author":"Horowitz","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2009.10.017","article-title":"Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer","volume":"46","author":"Gerestein","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.021_bb0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2016.11.022","article-title":"Chemotherapy delay after primary debulking surgery for ovarian cancer","volume":"144","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.021_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/IGC.0000000000000339","article-title":"Risk factors and indications for 30-day readmission after primary surgery for epithelial ovarian cancer","volume":"25","author":"AlHilli","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2015.10.025","article-title":"Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer","volume":"140","author":"Kumar","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.021_bb0040","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1245\/s10434-015-4938-9","article-title":"Is it time to centralize ovarian Cancer Care in the United States?","volume":"23","author":"Cowan","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2012.04.014","article-title":"Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer","volume":"126","author":"Tanner","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.11.021_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.02.019","article-title":"Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer","volume":"220","author":"Cham","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.11.021_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000658-199810000-00006","article-title":"The Department of Veterans Affairs\u2019 NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA surgical quality improvement program","volume":"228","author":"Khuri","year":"1998","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2020.11.021_bb0060","series-title":"User Guide for the 2015 ACS NSQIP Participant Use Data File (PUF)","year":"2015"},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2010.09.010","article-title":"Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment","volume":"120","author":"Aletti","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.021_bb0070","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2020.05.041","article-title":"A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: a memorial Sloan Kettering Cancer center team ovary initiative","volume":"158","author":"Straubhar","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.021_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","article-title":"A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer","volume":"145","author":"Suidan","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.021_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"issue":"8","key":"10.1016\/j.ygyno.2020.11.021_bb0090","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.021_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2015.03.043","article-title":"Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: analysis and management of complications in upper abdominal surgery","volume":"137","author":"Benedetti Panici","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2015.04.037","article-title":"Risk stratification and outcomes of women undergoing surgery for ovarian cancer","volume":"138","author":"Patankar","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.11.021_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2020.06.101","article-title":"Less guessing, more evidence in the decision for neoadjuvant chemotherapy versus surgery: a validated triage algorithm to identify women at high risk of morbidity\/mortality associated with ovarian cancer cytoreduction","volume":"159","author":"Narasimhulu","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.021_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/gyno.2002.6748","article-title":"Treatment preferences in recurrent ovarian cancer","volume":"86","author":"Donovan","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.021_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2015.11.030","article-title":"Endpoints in clinical trials: what do patients consider important? A survey of the ovarian Cancer National Alliance","volume":"140","author":"Minion","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2020.11.021_bb0120","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1002\/cncr.32447","article-title":"Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer","volume":"125","author":"Havrilesky","year":"2019","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2020.11.021_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.021_bb0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ygyno.2013.08.011","article-title":"Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies","volume":"131","author":"Uppal","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2014.07.103","article-title":"Impact of obesity on surgical and oncologic outcomes in ovarian cancer","volume":"135","author":"Kumar","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2019.08.004","article-title":"Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer","volume":"155","author":"Narasimhulu","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.021_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ygyno.2017.07.010","article-title":"Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery","volume":"147","author":"Schiavone","year":"2017","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820341329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820341329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:55:03Z","timestamp":1758772503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820341329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0090825820341329"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}